![](/wp-content/uploads/2023/08/Screenshot-2023-08-11-at-2.13.39-PM.png)
$599
Novo Q2 ’23 London Earnings; Akero Q2 ’23 Earnings Update
Two cardiometabolic-related news items have been observed: Novo Nordisk hosted its post-Q2 ’23 London earnings call (view webcast); and Akero reported its Q2 ’23 earnings (view press release). Below, FENIX provides highlights and insights from the respective news items.